8-K
filed January 24, 2023, 6:59 PM ET
ticker JNJ
CIK 0000200406
earnings
confidence high
sentiment positive
materiality 0.70
J&J Q4 sales fall 4.4% to $23.7B; adjusted EPS rises 10.3% to $2.35; 2023 guidance issued
JOHNSON & JOHNSON
2022-FY EPS reported
$6.73
revenue$94,943,000,000
- Q4 reported sales $23.7B, -4.4% YoY; operational growth ex-COVID vaccine +4.6%.
- Q4 GAAP EPS $1.33 (down 24.9%); adjusted EPS $2.35 (+10.3%).
- Full-year 2022 sales $94.9B (+1.3% reported); operational growth 6.1%.
- FY2022 GAAP EPS $6.73 (-13.8%); adjusted EPS $10.15 (+3.6%).
- 2023 guidance: adj. operational sales growth ex-COVID vaccine +4.0%; adj. EPS ~$10.50 (+3.5%).
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 1.0
JOHNSON & JOHNSON reported the fourth quarter ended January 1, 2023 results: revenue $23.7 Billion, EPS $1.33.
- Period
- the fourth quarter ended January 1, 2023
- Revenue
- $23.7 Billion
- EPS
- $1.33
- Result
- reported results
Exact text from the filing
• 2022 Fourth-Quarter reported sales decline of 4.4% to $23.7 Billion primarily driven by unfavorable foreign exchange and reduced COVID-19 Vaccine sales vs. prior year. Operational growth excluding COVID-19 Vaccine of 4.6%* • 2022 Fourth-Quarter earnings per share (EPS) of $1.33 decreasing 24.9% and adjusted EPS of $2.35 increasing by 10.3%*
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 1.0
JOHNSON & JOHNSON reported 2023 results: revenue 4.0%, EPS $10.50. Guidance initiated.
- Period
- 2023
- Revenue
- 4.0%
- EPS
- $10.50
- Guidance
- initiated
- Result
- guidance update
Exact text from the filing
Company guides 2023 adjusted operational sales growth excluding COVID-19 Vaccine of 4.0%* and adjusted operational EPS of $10.50, reflecting growth of 3.5%*
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 1.0
JOHNSON & JOHNSON reported the fiscal year ended January 1, 2023 results: revenue $94.9 Billion, EPS $6.73.
- Period
- the fiscal year ended January 1, 2023
- Revenue
- $94.9 Billion
- EPS
- $6.73
- Result
- reported results
Exact text from the filing
• 2022 Full-Year reported sales growth of 1.3% to $94.9 Billion primarily driven by strong commercial execution partially offset by unfavorable foreign exchange. Operational growth of 6.1%* • 2022 Full-Year earnings per share (EPS) of $6.73 decreasing 13.8% and adjusted EPS of $10.15 increasing by 3.6%*
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.